This isHOMEinCorporate InformationinCorporate Profilepages.

Corporate Profile


February 20, 1939


Manufacturing and sales of clinical diagnostics and equipments


6,897 million yen (March 31, 2018)

Stock Exchange Listings

First Section of the Tokyo Stock Exchange     code: 4549


Consolidated Results for the Year Ended

(millions of yen)
  March 31, 2016 March 31, 2017 March 31, 2018
Net sales 32,163 33,274 34,991
Operating income 3,536 3,976 3,478
Ordinary income 3,570 4,112 3,549
Net income 2,429 2,918 2,608

Directors        (June 22, 2017)

  1. Tetsuya Teramoto
  2. Morifumi Wada
  1. Takehisa Irisawa
  2. Kunio Uchiyamada
  3. Shigeru Nomura
  4. Yukiya Hakozaki
  5. Atsuoh Katsumata

Executive Officer    (April 1, 2018)

President & CEO Morifumi Wada
Vice President Executive Officer Masaaki Arakawa
Vice President Executive Officer Masaru Shioda
Executive Officer Tsugunori Noutomi
Executive Officer Norihisa Noguchi
Executive Officer Shinya Sadamoto
Executive Officer Kazuhisa Ueda
Executive Officer Hiroshi Wada
Executive Officer Katsushi Abe
Executive Officer Hajime Watari
Executive Officer Harufumi Tsuge
Executive Officer Naomichi Harada
Executive Officer Tomoyoshi Takahashi

Number of Employees

659 (March 31, 2018)

* Parent company only

Major Offices

4-19-9 Taito, Taito-ku, Tokyo, 110-8408, Japan

View Larger Map

* 4 minutes walk from JR Yamanote Line Okachimachi Sta.
* 3 minutes walk from Tokyo Metoro Hibiya Line Nakaokachimachi Sta.
* 5 minutes walk from Tokyo Metoro Ginza Line Uenohirokoji Sta.
* 5 minutes walk from Toei Oedo Line Shinokachimachi Sta.

Other Division

Europe Office
 Strawinskylaan 817 TW. A, 8F 1077XX Amsterdam, The Netherlands

Sales Office (Japan)
 Sapporo, Sendai, Tokyo-I, II, Yokohama, Nagoya, Kyoto, Osaka, Hiroshima, Takamatsu, Fukuoka
Nogi Division
 Factories, Research Laboratories
Nasu Division
  Factories, Research Laboratories